BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17786328)

  • 1. Differential expression of acidic proteins with progression in the MCF10 model of human breast disease.
    Buchanan NS; Zhao J; Zhu K; Patwa TH; Miller FR; Lubman DM
    Int J Oncol; 2007 Oct; 31(4):941-9. PubMed ID: 17786328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of estrogen response of premalignant human breast cells using a 2-D liquid separation/mass mapping technique.
    Zhao J; Zhu K; Lubman DM; Miller FR; Shekhar MP; Gerard B; Barder TJ
    Proteomics; 2006 Jul; 6(13):3847-61. PubMed ID: 16767785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protein molecular weight map of ES2 clear cell ovarian carcinoma cells using a two-dimensional liquid separations/mass mapping technique.
    Wang H; Kachman MT; Schwartz DR; Cho KR; Lubman DM
    Electrophoresis; 2002 Sep; 23(18):3168-81. PubMed ID: 12298089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatofocusing nonporous reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry of proteins from human breast cancer whole cell lysates: a novel two-dimensional liquid chromatography/mass spectrometry method.
    Chong BE; Yan F; Lubman DM; Miller FR
    Rapid Commun Mass Spectrom; 2001; 15(4):291-6. PubMed ID: 11223961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward high sequence coverage of proteins in human breast cancer cells using on-line monolith-based HPLC-ESI-TOF MS compared to CE MS.
    Yoo C; Pal M; Miller FR; Barder TJ; Huber C; Lubman DM
    Electrophoresis; 2006 Jun; 27(11):2126-38. PubMed ID: 16637017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of cold adaptation in a Siberian permafrost bacterium--Exiguobacterium sibiricum 255-15 by two-dimensional liquid separation coupled with mass spectrometry.
    Qiu Y; Kathariou S; Lubman DM
    Proteomics; 2006 Oct; 6(19):5221-33. PubMed ID: 16955517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation.
    Sarvaiya HA; Yoon JH; Lazar IM
    Rapid Commun Mass Spectrom; 2006; 20(20):3039-55. PubMed ID: 16986208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein pI shifts due to posttranslational modifications in the separation and characterization of proteins.
    Zhu K; Zhao J; Lubman DM; Miller FR; Barder TJ
    Anal Chem; 2005 May; 77(9):2745-55. PubMed ID: 15859589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
    Qu LJ; Ding YQ; Liang L
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein profiles and identification of high performance liquid chromatography isolated proteins of cancer cell lines using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chong BE; Lubman DM; Rosenspire A; Miller F
    Rapid Commun Mass Spectrom; 1998; 12(24):1986-93. PubMed ID: 10036781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
    Liu Y; Liu H; Han B; Zhang JT
    Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.
    Li DQ; Wang L; Fei F; Hou YF; Luo JM; ; Zeng R; Wu J; Lu JS; Di GH; Ou ZL; Xia QC; Shen ZZ; Shao ZM
    Proteomics; 2006 Jun; 6(11):3352-68. PubMed ID: 16637015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis.
    Turhani D; Krapfenbauer K; Thurnher D; Langen H; Fountoulakis M
    Electrophoresis; 2006 Apr; 27(7):1417-23. PubMed ID: 16568407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrow-band fractionation of proteins from whole cell lysates using isoelectric membrane focusing and nonporous reversed-phase separations.
    Zhu Y; Lubman DM
    Electrophoresis; 2004 Apr; 25(7-8):949-58. PubMed ID: 15095432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
    Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
    Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid screening of protein profiles of human breast cancer cell lines using non-porous reversed-phase high performance liquid chromatography separation with matrix-assisted laser desorption/ionization time-of-flight mass spectral analysis.
    Chong BE; Lubman DM; Miller FR; Rosenspire AJ
    Rapid Commun Mass Spectrom; 1999; 13(18):1808-12. PubMed ID: 10482893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
    Morita A; Miyagi E; Yasumitsu H; Kawasaki H; Hirano H; Hirahara F
    Proteomics; 2006 Nov; 6(21):5880-90. PubMed ID: 17022098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS.
    André M; Le Caer JP; Greco C; Planchon S; El Nemer W; Boucheix C; Rubinstein E; Chamot-Rooke J; Le Naour F
    Proteomics; 2006 Mar; 6(5):1437-49. PubMed ID: 16404722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.